Minako Iida
Overview
Explore the profile of Minako Iida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iida M, Ho A, Huang X, Liu K, Lv M, Huang H, et al.
Blood Cell Ther
. 2024 Dec;
7(4):129-137.
PMID: 39651061
COVID-19 became a global pandemic in 2020 and significantly affected the activity of hematopoietic cell transplants (HCT) worldwide. Despite these challenges, a total of 28,793 transplants, including 18,518 allogeneic and...
2.
Greinix H, Iftikhar R, Chaudhry Q, Ahmed P, Al-Khabori M, Gaziev J, et al.
Hematol Oncol Stem Cell Ther
. 2024 Oct;
17(3):190-199.
PMID: 39412755
The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell...
3.
Garderet L, Gras L, Koster L, Baaij L, Hamad N, DSouza A, et al.
Am J Hematol
. 2024 Aug;
99(11):2084-2095.
PMID: 39158218
Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and...
4.
Baldomero H, Neumann D, Hamad N, Atsuta Y, Sureda A, Iida M, et al.
Best Pract Res Clin Haematol
. 2024 Aug;
37(2):101556.
PMID: 39098798
Hematopoietic cell transplantation (HCT) was developed more than 65 years ago to treat malignant blood disorders and irreversible bone marrow failures, with the aim of replacing a diseased hematopoietic system...
5.
Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos J, Iida M, et al.
Haematologica
. 2024 May;
109(10):3282-3294.
PMID: 38721749
Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for...
6.
Iida M, Liu K, Huang X, Huang H, Kuwatsuka Y, Moon J, et al.
Blood Cell Ther
. 2023 Dec;
6(4):114-123.
PMID: 38149021
The number of hematopoietic stem cell transplantations (HCTs) is increasing annually worldwide, and the Asia-Pacific (AP) region is no exception. We report on the absolute number of HCTs in 2018...
7.
Iida M, Nakasone H, Yamashita T, Inoue M, Ishida Y, Uchiyama H, et al.
Blood Cell Ther
. 2023 Jul;
3(1):11-17.
PMID: 37465377
By evaluating risks of late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation (HSCT) in Japan, we clarified what we should focus on during...
8.
Okamoto S, Iida M, Hamad N, Duarte F, Sureda A, Srivastava A, et al.
Transplant Cell Ther
. 2023 Mar;
29(7):410-417.
PMID: 36921918
No abstract available.
9.
Iida M, Liu K, Huang X, Depei W, Kuwatsuka Y, Moon J, et al.
Blood Cell Ther
. 2023 Jan;
5(4):87-98.
PMID: 36713681
The Asia-Pacific Blood and Marrow Transplantation Group (APBMT) has been conducting annual surveys on the activity of hematopoietic stem cell transplants since 2007. The APBMT Data Center collected the following...
10.
Iida M, Dodds A, Akter M, Srivastava A, Moon J, Dung P, et al.
Blood Cell Ther
. 2023 Jan;
4(2):20-28.
PMID: 36712901
This report describes the results of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT) Activity Survey 2016, focusing on the trends of haploidentical and cord blood (CB) transplants in the...